Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „described“
Suchtreffer
Begriffe & Kennungen
Advagraf · 4.8 · Description of selected adverse reactions Pain in extremity has been described in a number of published case r
Eintrag öffnenAfqlir · 4.8 · The safety data described below include all adverse reactions from the eight phase III studies in the indicati
Eintrag öffnenAfqlir · 4.8 · The safety data described below include all adverse reactions from the eight phase III studies in the indicati
Eintrag öffnenAhzantive · 4.8 · 7 The safety data described below include all adverse reactions from the eight phase III studies in the indica
Eintrag öffnenAhzantive · 4.8 · The safety data described below include all adverse reactions from the eight phase III studies in the indicati
Eintrag öffnenAkeega · 4.8 · Description of selected adverse reactions The selected adverse reactions described below are based on pooled d
Eintrag öffnenAlecensa · 4.8 · The data described below reflect exposure to Alecensa in 533 patients with resected or advanced ALK-positive N
Eintrag öffnenApixaban Accord · 4.5 · In studies conducted in healthy subjects, as described below, apixaban did not meaningfully alter the pharmaco
Eintrag öffnenApixaban Accord · 4.5 · In studies conducted in healthy subjects, as described below, apixaban did not meaningfully alter the pharmaco
Eintrag öffnenAtosiban SUN · 4.8 · Possible adverse reactions of atosiban were described for the mother during the use of atosiban in clinical tr
Eintrag öffnenAtosiban SUN · 4.8 · Possible adverse reactions of atosiban were described for the mother during the use of atosiban in clinical tr
Eintrag öffnenBaiama · 4.8 · The safety data described below include all adverse reactions from the eight phase III studies in the indicati
Eintrag öffnenBaiama · 4.8 · The safety data described below include all adverse reactions from the eight phase III studies in the indicati
Eintrag öffnenBalversa · 4.8 · Abnormal laboratory findings Abnormal laboratory findings (other than hyperphosphataemia, which is described s
Eintrag öffnenBavencio · 4.8 · The management guidelines for these adverse reactions are described in section 4.4.
Eintrag öffnenBlincyto · 4.8 · The adverse reactions described in this section were identified in clinical studies of patients with B-cell pr
Eintrag öffnenBusulfan Fresenius Kabi · 4.5 · Paracetamol is described to decrease glutathione levels in blood and tissues, and may therefore decrease busul
Eintrag öffnenBusulfan Fresenius Kabi · 4.5 · Published studies in adults described that ketobemidone (analgesic) might be associated with high levels of pl
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.5 · All adult drug-drug interaction studies described above were conducted at a 50 or 70 mg daily caspofungin dose
Eintrag öffnenCapecitabine Accord · 4.8 · Cardiotoxicity (see section 4.4) In addition to the ADRs described in tables 4 and 5, the following ADRs with
Eintrag öffnen